$AMGN

AI 分析

生成于 May 18, 2026

AI Score
74/ 100
Buy$AMGN

Amgen Inc.

$AMGNNASDAQHealthcareLarge-Cap

Amgen discovers, develops, manufactures, and delivers human therapeutics worldwide focusing on inflammation, oncology, and cardiovascular disease.

Market Cap
$165B
Revenue (TTM)
$34.5B
+18.5%
Net Income (TTM)
$6.8B
+12.2%
EPS (TTM)
$12.52
P/E Ratio
24.5
Dividend Yield
2.8%
52-Week Range
$265-$335
Beta
0.58
Dimension Scores
Fundamental
78
Technical
70
Sentiment
74
Risk / Reward
74
Momentum
68
FundTechSentRiskMome
Financial Health
Profitability
78moderate
Growth
75moderate
Liquidity
72moderate
Solvency
62moderate
Efficiency
76moderate

Valuation, technical analysis, investment thesis, risk assessment and more for $AMGN

Free · No credit card required

免责声明: AI 生成的分析仅供教育参考,不构成投资建议。请始终咨询合格的理财顾问。

探索更多

用 AI 分析任意股票

获取涵盖基本面、技术面、情绪面、风险评估和投资论点的结构化研究报告——约 60 秒完成。